Efficacy of marijuana in treating chronic non cancer pain: a short review

WCB Evidence Based Practice Group
Record ID 32006000866
English
Authors' objectives:

The objectives of this short systematic review are to answer following questions:

Is cannabis or cannabinoid, natural or synthetic (including Marinol, Sativex, Cesamet) effective in treating chronic non cancer pain?

Is there any new evidence to change the WorkSafeBC policy on marijuana use in treating chronic non cancer pain?

Authors' recommendations: At present, there is no evidence on the effectiveness of cannabis or cannabinoids in treating patients with chronic non-malignant pain. Given the current availability of evidence on the effectiveness of cannabis or cannabinoids on treating chronic non-malignant pain, the EBPG suggests that the WorkSafeBC policy on the 'medicinal use' of cannabis or cannabinoids in treating chronic pain, as outlined in the 2002 paper entitled "Marijuana for medicinal purposes: an evidence based assessment" remains appropriate and should not be modified.
Authors' methods: Review
Details
Project Status: Completed
Year Published: 2006
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Cannabinoids
  • Cannabis
  • Pain
Contact
Organisation Name: WorkSafeBC
Contact Address: 6591 Westminster Highway, Richmond, BC, V7C 1C6 Canada. Tel: 604-231-8417; Fax: 604-279-7698
Contact Name: ebpg@worksafebc.com
Contact Email: ebpg@worksafebc.com
Copyright: WorkSafe BC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.